Keywords: eu, majors, agree, serd, deal, anglo-swedish, drug

Two EU majors agree SERD R&D deal

Article | 25 September 2006

Print This

Anglo-Swedish drug major AstraZeneca and Germany's Schering AG say they have agreed to jointly develop and commercialize a selective estrogen ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in